Nudges improve food choices and cut calories when shopping for groceries online
A team of Duke-NUS Medical School researchers designed and tested a new digital toolkit that helps consumers make healthier grocery choices online — an innovation that could play a major role in the global fight against chronic diseases such as heart disease, stroke and diabetes. In their study, published in the American Journal of Preventive […]
FDA Clears AI-Powered Non-Invasive Skin Cancer Detector
The FDA cleared an artificial-intelligence (AI)-powered device designed to non-invasively detect skin cancer in the primary care setting, the agency announced on Tuesday. Developer DermaSensor said the device uses AI-powered spectroscopy technology to non-invasively evaluate cellular and subcellular characteristics of a lesion for any of the three common skin cancers — melanoma, basal cell carcinoma, […]
Women with a heart healthy diet in midlife are less likely to report cognitive decline later
Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds. Led by researchers from NYU Grossman School of Medicine, the new findings suggest that a mid-life lifestyle modification — adoption of the […]
A Game-Changing Pill For Postpartum Depression Was Just Approved By The FDA
Feinstein Institute A photo of zuranolone, the first pill designed to treat postpartum depression, from its phase 3 clinical trial. The Food and Drug Administration on Friday approved the first-ever pill specifically designed to treat postpartum depression. Taken once a day for two weeks, the drug, called zuranolone and marketed as Zurzuvae, can rapidly and […]
Researchers design an innovative strategy to fight obesity through gene therapy
A scientific team from the University of Barcelona and the CIBERobn has designed a strategy to fight obesity and diabetes in mice through ex vivo gene therapy which consists of implanting cells that have been manipulated and transformed in order to treat a disease. This is the first study to apply the ex vivo gene […]
Novel Chemo Delivery System Achieves High Response Rate in Bladder Cancer
CHICAGO — An investigational intravesical delivery system designed to provide sustained local release of gemcitabine into the bladder produced high rates of complete response (CR) in difficult-to-treat non-muscle-invasive bladder cancer (NMIBC), data from an ongoing phase IIb study showed. Preliminary results from the SunRISe-1 trial demonstrated that monotherapy with the novel treatment, dubbed TAR-200, led […]
The Best Foam Rollers, According To Physical Therapists
Nidhi Sharma, a New York City-based physical therapist, recommended this anatomically designed foam roller because of its unique design. “Its shape is ideal to be used on a spine. It has a groove that fits the spine perfectly and the curves on the side hug the muscles of the back very well. I think patients […]
Study identifies receptor that could alleviate need for chemo, radiation pre-T cell therapy
Before a patient can undergo T cell therapy designed to target cancerous tumors, the patient’s entire immune system must be destroyed with chemotherapy or radiation. The toxic side effects are well known, including nausea, extreme fatigue and hair loss. Now a research team, led by UCLA’s Anusha Kalbasi, MD, in collaboration with scientists from Stanford […]
Texas Medical Association Sues Feds Over Surprise Billing
The Texas Medical Association (TMA) is challenging a federal law designed to shield patients from surprise medical bills, arguing in a new lawsuit that regulators have stacked the deck against healthcare providers in their implementation of the No Surprises Act. Essentially, TMA takes issue with the arbitration process for settling out-of-network bills, arguing that the […]
COVID Prevention Tx Safe, Shows Efficacy in High-Risk Groups
A monoclonal antibody cocktail designed for COVID-19 pre-exposure prophylaxis was safe, and appeared to be effective across populations at risk of severe COVID and who may have a subpar response to vaccination, a researcher said. AZD7442 (tixagevimab/cilgavimab) met its primary endpoint, reducing the risk of symptomatic COVID-19 among high-risk populations by 77% (95% CI 46%-90%), […]